| P50 | author | Paige Lacy | Q46368786 |
| P2093 | author name string | Zhao Yang | |
| | Kirk M Druey | |
| | Zhihui Xie | |
| | Helene F Rosenberg | |
| | Redwan Moqbel | |
| | Kimberly D Dyer | |
| | Caroline M Percopo | |
| | Francis Davoine | |
| | John Dongil Kim | |
| P2860 | cites work | Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation | Q24528229 |
| | Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor | Q24679152 |
| | The G Protein-Coupled Receptor GPR4 Suppresses ERK Activation in a Ligand-Independent Manner | Q28211122 |
| | Platelet-activating factor receptor | Q28214944 |
| | Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism | Q28271624 |
| | Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4 | Q28295925 |
| | Previously postulated "ligand-independent" signaling of GPR4 is mediated through proton-sensing mechanisms | Q28299617 |
| | A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning and characterization of acetyl-CoA:LYSO-PAF acetyltransferase | Q28589711 |
| | Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice | Q28609411 |
| | beta-Arrestin 1 participates in platelet-activating factor receptor-mediated endocytosis of Streptococcus pneumoniae | Q30476507 |
| | Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. | Q30489042 |
| | Agonists of the orphan human G2A receptor identified from inducible G2A expression and beta-lactamase reporter screen | Q33463693 |
| | Isolation of human eosinophils: microbead method has no impact on IL-5 sustained viability | Q33884747 |
| | Eosinophil cytokines | Q33889418 |
| | Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen | Q47951192 |
| | Eosinophils: biological properties and role in health and disease. | Q51960619 |
| | The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils | Q67596956 |
| | Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor | Q68329529 |
| | Specific high affinity binding of platelet activating factor to intact human blood neutrophils and eosinophils | Q71115316 |
| | Detection of IL-5 and IL-1 receptor antagonist in bronchoalveolar lavage fluid in acute eosinophilic pneumonia | Q71120320 |
| | CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor | Q71624306 |
| | Recombinant human platelet-activating factor-acetylhydrolase inhibits airway inflammation and hyperreactivity in mouse asthma model | Q73520608 |
| | Cutting edge: eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils | Q73720769 |
| | Characterization of platelet-activating factor-induced cytosolic calcium mobilization in human eosinophils | Q73738612 |
| | Platelet-activating factor antagonists | Q73934182 |
| | Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses | Q74139228 |
| | Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma | Q74417771 |
| | Release of granule proteins from human eosinophils stimulated with mast-cell mediators | Q77577332 |
| | Evidence for an association between plasma platelet-activating factor acetylhydrolase deficiency and increased risk of childhood atopic asthma | Q77826813 |
| | Coexpression of IL-5 and eotaxin-2 in mice creates an eosinophil-dependent model of respiratory inflammation with characteristics of severe asthma | Q80427980 |
| | Role of platelet-activating factor in cardiovascular pathophysiology. | Q34051712 |
| | Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. | Q34480114 |
| | Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis | Q34586645 |
| | Cytokines and chemoattractants in allergic inflammation | Q34636517 |
| | Anaphylaxis: lessons from mouse models | Q34674225 |
| | Dual signaling and effector pathways mediate human eosinophil activation by platelet-activating factor | Q35786039 |
| | Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases | Q35928530 |
| | Molecular mechanisms of anaphylaxis: lessons from studies with murine models. | Q36064748 |
| | Eosinophil degranulation: an evolutionary vestige or a universally destructive effector function? | Q36239677 |
| | Eosinophilia in transgenic mice expressing interleukin 5. | Q36353850 |
| | Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor | Q36400935 |
| | Plasma PAF-acetylhydrolase: an unfulfilled promise? | Q36522538 |
| | Eosinophil trafficking in allergy and asthma. | Q36811728 |
| | Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins | Q36944424 |
| | Platelet activating factor as a mediator and therapeutic approach in bronchial asthma | Q37056330 |
| | Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially | Q37062148 |
| | Functionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow | Q37187744 |
| | Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. | Q37274179 |
| | Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation | Q37286185 |
| | Newly discovered roles for basophils: a neglected minority gains new respect. | Q37336604 |
| | PDGF-induced human airway smooth muscle cell proliferation requires STAT3 and the small GTPase Rac1. | Q38293095 |
| | Platelet activating factor: a biologically active phosphoglyceride | Q39503946 |
| | Platelet activating factor antagonists | Q40524595 |
| | Platelet-activating factor: the biosynthetic and catabolic enzymes | Q40587398 |
| | Platelet-activating factor antagonists: scientific background and possible clinical applications. | Q40699752 |
| | Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. | Q40920142 |
| | Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung | Q41699178 |
| | The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils | Q41947992 |
| | Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation | Q42563701 |
| | Vesicle-mediated secretion of human eosinophil granule-derived major basic protein. | Q43105476 |
| | Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor | Q44096280 |
| | Distinct isoforms of protein kinase C are involved in human eosinophil functions induced by platelet-activating factor | Q44456685 |
| | Stimulation of degranulation from human eosinophils by platelet-activating factor | Q44876673 |
| | The induction of eosinophil peroxidase release: improved methods of measurement and stimulation | Q45042220 |
| | Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils | Q45126696 |
| | Bronchoconstriction Induced by Platelet-Activating Factor in the Guinea Pig and Its Inhibition by CV-3988, a PAF Antagonist: Serial Changes in Findings of Lung Histology and Bronchoalveolar Lavage Cell Population | Q46314000 |
| | Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis | Q46700754 |
| | PAF-receptors on eosinophils: identification with a novel ligand, [3H]WEB 2086. | Q46810362 |
| | Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation | Q46913829 |
| | Platelet-activating factor receptor develops airway hyperresponsiveness independently of airway inflammation in a murine asthma model | Q47578603 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human eosinophil | Q101405048 |
| P304 | page(s) | 6327-6334 | |
| P577 | publication date | 2010-04-26 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor | |
| P478 | volume | 184 | |